Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amelubant Dose-Ranging Study in COPD
NCT02249247Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2001
- Primary completion
- Aug 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of amelubant in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Apr 2001; status: completed.
02
Drugs
amelubant
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02249247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02249247.